The role of scavenger-receptor class A and B in the metabolism of modified LDL and HDL

1999 ◽  
Vol 144 ◽  
pp. 83 ◽  
Author(s):  
T.J.C. van Berkel ◽  
K. Fluiter ◽  
S. Nion ◽  
J.K. Kruyt
1999 ◽  
Vol 250 (1) ◽  
pp. 264-271 ◽  
Author(s):  
Agnes G van Velzen ◽  
Hiroshi Suzuki ◽  
Tatsuhiko Kodama ◽  
Theo J.C van Berkel

PLoS ONE ◽  
2014 ◽  
Vol 9 (10) ◽  
pp. e109531 ◽  
Author(s):  
Mami Shimizu ◽  
Hisafumi Yasuda ◽  
Kenta Hara ◽  
Kazuma Takahashi ◽  
Masao Nagata ◽  
...  

2021 ◽  
Author(s):  
Yi Li ◽  
Feng Peng ◽  
Xiangyun Tan ◽  
Jin Wang ◽  
Yeqing Xu

Abstract Background Colorectal cancer (CRC) exhibits high risks of morbidity and mortality. Objective To investigate the effect of scavenger receptor class A member 5 (SCRAR5) on CRC and its mechanism on modulation of cancer development. Methods The SCRAR5 expression in four kinds of CRC cell lines (SW620, SW480, HT29, and HCT116) was measured by quantitative PCR and western blotting, respectively. The effects of SCRAR5 abnormal expression on cell proliferation, apoptosis, and migration were analyzed by CCK-8 assay, EdU assay, colony-forming assay, flow cytometry assay, Transwell assay and wound healing assay, respectively. Meanwhile, the involvements of PI3K/AKT/mTOR pathway with the role of SCRAR5 were investigated by western blotting. Afterwards, the in vivo effects of SCRAR5 abnormal expression on CRC xenograft mice were finally investigated by evaluating tumor volume, apoptosis and Ki67 expression. Results SCRAR5 was lowly expressed in CRC cell lines, especially SW480 cells. Up-regulation of SCRAR5 significantly promoted cell apoptosis, reduced cell proliferation and migration in SW480 cells. Notably, SCRAR5 overexpression obviously inhibited the phosphorylation levels of PI3K, AKT, and mTOR. Reversely, SCRAR5 silence exhibited promoting effects on HT29 cells. Consistently, in vivo experiments also revealed that SCRAR5 overexpression remarkably suppressed tumor volume and Ki67 expression, as well as promoted cell apoptosis. Conclusions Overall, up-regulating of SCRAR5 obviously inhibited CRC tumor growth in vitro and in vivo, which might be related to PI3K/AKT/mTOR pathway.


2000 ◽  
Vol 164 (9) ◽  
pp. 4861-4867 ◽  
Author(s):  
Nick Platt ◽  
Hiroshi Suzuki ◽  
Tatsuhiko Kodama ◽  
Siamon Gordon

2016 ◽  
Vol 6 (7) ◽  
pp. 567-572
Author(s):  
Aamir Rana ◽  
Syed Sajjad Sattar ◽  
Afshann Shahzad ◽  
Ghulam Muhammad Ali ◽  
Yasir Waheed

Sign in / Sign up

Export Citation Format

Share Document